Membrane proteomics of cellular responses to β-blocker carvedilol
Carvedilol is a third generation β-blocker of multifaceted therapeutic potential. It is a non-selective antagonist of β1 and, β2 adrenoceptors and exhibits anti-α1–adrenergic activity. Clinically, carvedilol has been used in the treatment of congestive heart failure, ischemic heart disease and hyper...
Saved in:
Main Author: | Wee, Kai Fa. |
---|---|
Other Authors: | Chen Wei Ning, William |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/38936 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Proteomics and metabolomics analysis of cellular responses to β-blocker carvedilol
by: Wang, Mingxuan
Published: (2012) -
Proteomics and metabolomics analysis of cellular response to anti-coagulating drug warfarin
by: Bai, Jing
Published: (2011) -
Metabolomics of beta-blockers
by: Tan, Ian Yong Ming.
Published: (2010) -
Cellular response to synthetic drugs : a metabolomics approach
by: Chen, William Wei Ning.
Published: (2009) -
Inhibition of cellular HBV replication by bovine lactoferrin.
by: Lee, Benedict Jia Hong.
Published: (2010)